Concord Medical Services Holdings Limited - ADR Financials
$3.50
As on 25-Sep-2026 13:30EDT
Market cap
$16 Mln
Revenue (TTM)
$448 Mln
P/E Ratio
--
P/B Ratio
3
Div. Yield
0 %
Income Statement (CN¥ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
460.51
|
383.96
|
537.40
|
472.09
|
485.63
|
223.01
|
|||||
|
Cost of Revenue
|
434.69
|
463.12
|
614.01
|
624.49
|
542.53
|
209.93
|
|||||
|
Gross Profit
|
25.82
|
-79.16
|
-76.61
|
-152.41
|
-56.90
|
13.08
|
|||||
|
Operating Expenses
|
265.15
|
453.00
|
386.38
|
372.64
|
401.42
|
320.58
|
|||||
|
Operating Profit (EBIT)
|
-239.33
|
-532.16
|
-462.99
|
-525.05
|
-458.32
|
-307.50
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-373.36
|
-669.58
|
-555.59
|
-839.90
|
-529.24
|
-441.65
|
|||||
|
Provision for Tax
|
6.06
|
-17.51
|
-24.57
|
-70.91
|
-6.57
|
-37.62
|
|||||
|
Profit after Tax (Net Income)
|
-92.81
|
-308.24
|
-297.66
|
-489.66
|
-271.43
|
-404.03
|
|||||
|
Minority Interest
|
286.61
|
343.83
|
233.36
|
279.33
|
251.25
|
3,063.79
|
|||||
|
Consolidated Profit
|
--
|
-308.24
|
-297.66
|
-489.66
|
-820.62
|
-669.91
|
Liabilities (CN¥ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-2,103.11
|
-2,280.39
|
-2,121.95
|
-1,863.97
|
-1,370.12
|
2,400.83
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
2,742.84
|
2,983.28
|
2,355.56
|
2,868.04
|
2,681.71
|
2,421.59
|
|||||
|
Current Liabilities
|
1,954.41
|
2,125.36
|
1,951.39
|
1,121.24
|
804.52
|
512.12
|
|||||
|
Total Liabilities
|
6,547.36
|
6,726.39
|
6,053.94
|
6,004.93
|
6,229.95
|
5,334.54
|
Assets (CN¥ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
5,605.45
|
5,742.42
|
5,436.74
|
5,245.13
|
5,645.48
|
4,658.54
|
|||||
|
Current Assets
|
941.91
|
983.97
|
617.21
|
759.80
|
584.48
|
676.00
|
|||||
|
Total Assets
|
6,547.36
|
6,726.39
|
6,053.94
|
6,004.93
|
6,229.95
|
5,334.54
|
|||||
|
Total Debt*
|
3,634.99
|
3,930.73
|
3,295.70
|
3,239.88
|
2,732.66
|
2,354.06
|
|||||
|
Net Current Assets
|
-1,012.50
|
-1,141.38
|
-1,334.19
|
-361.44
|
-220.05
|
163.88
|
Cashflow (CN¥ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-201.82
|
-397.75
|
-276.47
|
-216.69
|
-359.31
|
-229.77
|
|||||
|
Cash Flow from Investing Activities
|
53.97
|
-593.44
|
-47.68
|
-118.79
|
-565.98
|
-533.89
|
|||||
|
Cash from Financing Activities
|
197.23
|
1,146.03
|
257.65
|
383.09
|
642.45
|
1,138.30
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (CN¥)
|
-637.44
|
-2.37
|
-2,044.35
|
-3.76
|
-2.08
|
-3.10
|
|||||
|
Cash EPS (CN¥)
|
387.67
|
-1.36
|
-1,162.12
|
-2.74
|
-1.28
|
-2.49
|
|||||
|
Adjusted Book Value (CN¥)
|
--
|
--
|
--
|
--
|
--
|
18.43
|
|||||
|
Dividend per Share (CN¥)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (CN¥)
|
-1,386.15
|
-3.05
|
-1,898.84
|
-1.66
|
-2.76
|
-1.76
|
|||||
|
Free Cash Flow per Share (CN¥)
|
-2,013.45
|
-6.21
|
-2,693.50
|
-4.61
|
-8.60
|
-5.70
|
Profitability Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
-5.83
|
-21.83
|
-23.35
|
-35.76
|
-8.87
|
-13.13
|
|||||
|
ROE (%)
|
4.23
|
14.00
|
14.94
|
30.28
|
-52.67
|
-35.47
|
|||||
|
ROA (%)
|
-1.40
|
-4.82
|
-4.94
|
-8.00
|
-4.69
|
-8.39
|
|||||
|
EBIT Margin (%)
|
-48.00
|
-124.07
|
-86.15
|
-111.22
|
-94.38
|
-137.89
|
|||||
|
Net Margin (%)
|
-20.15
|
-80.28
|
-55.39
|
-103.72
|
-55.89
|
-181.17
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.20
|
-0.29
|
0.14
|
-0.03
|
1.18
|
0.12
|
|||||
|
EBIT Growth (%)
|
53.60
|
-2.89
|
11.82
|
-14.56
|
-49.05
|
14.87
|
|||||
|
Net Profit Growth (%)
|
69.89
|
-3.56
|
39.21
|
-80.40
|
32.82
|
-31.58
|
|||||
|
EPS Growth (%)
|
-268.36
|
1.00
|
-542.81
|
-0.80
|
0.33
|
-0.32
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
-1.73
|
-1.72
|
-1.55
|
-1.74
|
-1.99
|
0.98
|
|||||
|
Short term debt to equity ratio
|
-0.49
|
-0.47
|
-0.51
|
-0.29
|
-0.23
|
0.07
|
|||||
|
Current Ratio
|
0.48
|
0.46
|
0.32
|
0.68
|
0.73
|
1.32
|
|||||
|
Quick Ratio
|
0.46
|
0.45
|
0.30
|
0.60
|
0.68
|
1.28
|
|||||
|
Interest Coverage
|
-1.45
|
-2.47
|
-2.79
|
-4.36
|
-6.21
|
-3.78
|
Operating Efficiency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
9.57
|
13.33
|
13.68
|
27.59
|
78.87
|
125.73
|
|||||
|
Asset Turnover
|
0.07
|
0.06
|
0.09
|
0.08
|
0.08
|
0.05
|
|||||
|
Receivable days
|
37.76
|
59.30
|
69.25
|
198.57
|
249.49
|
328.82
|
|||||
|
Inventory Days
|
33.36
|
29.10
|
37.23
|
35.95
|
20.09
|
22.58
|
|||||
|
Payable days
|
133.89
|
129.59
|
82.09
|
72.89
|
40.78
|
23.41
|
|||||
|
Cash Conversion Cycle
|
-62.77
|
-41.20
|
24.39
|
161.63
|
228.80
|
327.99
|